Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse model

Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse model

10.1158/1535-7163.MCT-13-0056

Saved in:

Bibliographic Details
Main Authors:	Sia, K.C., Huynh, H., Chung, A.Y.F., Ooi, L.L.P.J., Lim, K.H., Hui, K.M., Lam, P.Y.P.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110611
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

?-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
by: Siveen K.S., et al.
Published: (2020)

γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
by: Siveen, K.S., et al.
Published: (2014)

A dual tracer 18F-FCH/18F-FDG PET imaging of an orthotopic brain tumor xenograft model
by: Fu Y., et al.
Published: (2018)

Emodin Suppresses Migration and Invasion through the Modulation of CXCR4 Expression in an Orthotopic Model of Human Hepatocellular Carcinoma
by: Manu, K.A., et al.
Published: (2014)

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
by: Huynh, H, et al.
Published: (2011)

Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
by: Subramaniam, A., et al.
Published: (2014)

Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model
by: Ong, L.-C., et al.
Published: (2014)

In vivo measurement of gadolinium diffusivity by dynamic contrast-enhanced MRI: A preclinical study of human xenografts
by: Koh, T.S., et al.
Published: (2016)

Partial Substitution of Glucose with Xylitol Prolongs Survival and Suppresses Cell Proliferation and Glycolysis of Mice Bearing Orthotopic Xenograft of Oral Cancer
by: Sahasakul Y.
Published: (2023)

Human mesenchymal stem cells preferentially migrate toward highly oncogenic human hepatocellular carcinoma cells with activated EpCAM signaling
by: Endaya B, et al.
Published: (2020)

AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma
by: Huynh, H, et al.
Published: (2020)

Reduced plasma APOA1 level is associated with Gastric Tumor Growth in MKN45 mouse xenograft model
by: Chong, P.-K., et al.
Published: (2014)

Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
by: Huynh, H., et al.
Published: (2012)

Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
by: Huynh, H., et al.
Published: (2011)

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
by: Risbridger, Gail P., et al.
Published: (2022)

Partial Substitution of Glucose with Xylitol Prolongs Survival and Suppresses Cell Proliferation and Glycolysis of Mice Bearing Orthotopic Xenograft of Oral Cancer
by: Yuraporn Sahasakul, et al.
Published: (2022)

An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia
by: Her Z., et al.
Published: (2020)

Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma
by: Wang, Weining, et al.
Published: (2015)

Tumor and microenvironment modification during progression of murine orthotopic bladder cancer
by: Tham, S.M., et al.
Published: (2014)

Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers
by: Li F., et al.
Published: (2020)

MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma
by: Xia, H., et al.
Published: (2014)

A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma
by: Zhong, L, et al.
Published: (2020)

Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel
by: Fong, E.L.S., et al.
Published: (2021)

Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
by: Zhao Y., et al.
Published: (2019)

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Imaging Biomarker for Vascular Normalization Effect of Infigratinib in High-FGFR-Expressing Hepatocellular Carcinoma Xenografts
by: Huynh The Hung
Published: (2022)

ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
by: Jasinghe, V.J., et al.
Published: (2011)

Early detection of antiangiogenic treatment responses in a mouse xenograft tumor model using quantitative perfusion MRI
by: Rajendran, R, et al.
Published: (2020)

Altered binding site selection of p53 transcription cassettes by hepatitis B virus X protein
by: Chan, C., et al.
Published: (2014)

Identification of proteins differentially expressed between capillary endothelial cells of hepatocellular carcinoma and normal liver in an orthotopic rat tumor model using 2-D DIGE
by: Jia, J., et al.
Published: (2014)

Celastrol attenuates the invasion and migration and augments the anticancer effects of bortezomib in a xenograft mouse model of multiple myeloma
by: Shanmugam, M.K, et al.
Published: (2020)

Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis
by: Mah W.-C., et al.
Published: (2018)

Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma
by: Wang, S.M., et al.
Published: (2014)

MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms
by: Wang, Y., et al.
Published: (2014)

Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signaling
by: Shen, J., et al.
Published: (2011)

Control of optical contrast using gold nanoshells for optical coherence tomography imaging of mouse xenograft tumor model in vivo
by: Kah, J.C.Y., et al.
Published: (2014)

A sensitive liquid chromatography-tandem mass spectrometry method for the determination of nimbolide in mouse serum: Application to a preclinical pharmacokinetics study
by: Wang, L, et al.
Published: (2020)

The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma
by: Xia H., et al.
Published: (2020)

Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo
by: Rajendran, P., et al.
Published: (2014)

Number of Nodules, Child-Pugh Status, Margin Positivity, and Microvascular Invasion, but not Tumor Size, are Prognostic Factors of Survival after Liver Resection for Multifocal Hepatocellular Carcinoma
by: Goh, B.K.P., et al.
Published: (2016)

Network of clinically-relevant lncRNAs-mRNAs associated with prognosis of hepatocellular carcinoma patients
by: Lim, L.J., et al.
Published: (2021)